Allergen-induced airway reactions in atopic asthmatics correlate with allergen-specific IL-5 response by BAL cells
- 1 March 1997
- journal article
- clinical trial
- Published by Wiley in Respirology
- Vol. 2 (1), 45-55
- https://doi.org/10.1111/j.1440-1843.1997.tb00053.x
Abstract
Allergen-specific cytokine responses in the airways are thought to play a critical role in the pathogenesis of atopic asthma. This study examined whether there is a quantitative difference in bronchoalveolar lavage (BAL) cell allergen-induced IL-5 production between atopic subjects with and without asthma which may relate to a difference in airway response induced by allergen exposure. Twelve atopic asthmatics (AA), nine atopic non-asthmatics (AN) and 10 normal controls (N) underwent inhalation challenge with house dust mite allergen (HDM) extract. AA differed from AN in having late airway reactions (LAR) after HDM inhalation (P < 0.01), which correlated with an increased percentage of BAL eosinophils and increased BAL cell IL-5 production after in vivo or in vitro HDM challenge for the AA group (P < 0.01). IL-5 production by PBMC from both atopic groups was elevated with HDM stimulation in vitro, but AA again had a higher level under baseline conditions than AN (P < 0.02). Furthermore, there was a greater effect of BAL fluid from AA on ECP release by eosinophils compared to that for AN (P < 0.01). These findings suggest that increased IL-5 production in atopic asthmatic airways contributes to the increased physiological response to allergen inhalation, by modulating local eosinophil recruitment and activation.Keywords
This publication has 35 references indexed in Scilit:
- Phenotype of cells expressing mRNA for TH2-type (interleukin 4 and interleukin 5) and TH1-type (interleukin 2 and interferon gamma) cytokines in bronchoalveolar lavage and bronchial biopsies from atopic asthmatic and normal control subjects.American Journal of Respiratory Cell and Molecular Biology, 1995
- Activated T cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia.American Journal of Respiratory and Critical Care Medicine, 1994
- Eosinophil survival activity identified as interleukin-5 is associated with eosinophil recruitment and degranulation and lung injury twenty-four hours after segmental antigen lung challengeJournal of Allergy and Clinical Immunology, 1993
- Activation of CD4+ T cells, increased TH2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthmaJournal of Allergy and Clinical Immunology, 1993
- Increases in Activated T Lymphocytes, Eosinophils, and Cytokine mRNA Expression for Interleukin-5 and Granulocyte/Macrophage Colony-stimulating Factor in Bronchial Biopsies after Allergen Inhalation Challenge in Atopic AsthmaticsAmerican Journal of Respiratory Cell and Molecular Biology, 1993
- Allergic and Nonallergic Asthmatics Have Distinct Patterns of T-Cell Activation and Cytokine Production in Peripheral Blood and Bronchoalveolar LavageAmerican Review of Respiratory Disease, 1992
- “Helper” (CD4+) T Cells and Eosinophils in Allergy and AsthmaAmerican Review of Respiratory Disease, 1992
- Asthma and inflammationJournal of Allergy and Clinical Immunology, 1991
- Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4, IL-5, and granulocyte/macrophage colony-stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects.The Journal of Experimental Medicine, 1991
- The eosinophil and bronchial asthma: Current understandingJournal of Allergy and Clinical Immunology, 1990